Altria shares drop after National Cancer Institute director named acting head of FDA - Yahoo Finance
- Altria shares drop after National Cancer Institute director named acting head of FDA Yahoo Finance
- Nation’s cancer chief appointed acting FDA commissioner The Washington Post
- Altria shares hit after National Cancer Institute director named acting head of the FDA CNBC
- Nation’s cancer chief appointed acting FDA commissioner The Washington Post
- National Cancer Institute Director Ned Sharpless named acting FDA commissioner CNBC
- View full coverage on Google News